Heparan sulfate storage in the cardiac conduction system triggers atrioventricular block

Abstract Objective To elucidate the novel biological functions of heparan sulfate (HS) by clinic-pathologically studying a patient with paroxysmal atrioventricular (AV) block. Patient A long-surviving male patient with Sanfilippo syndrome type A presented with paroxysmal AV block at age 33 years. He...

Full description

Saved in:
Bibliographic Details
Published inBrain & development (Tokyo. 1979) Vol. 39; no. 5; pp. 418 - 421
Main Authors Kato, Rie, Miyahara, Hiroaki, Kawano, Tatsuya, Matsuzuka, Atsuko, Noda, Kimiko, Izumi, Tatsuro
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 01.05.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract Objective To elucidate the novel biological functions of heparan sulfate (HS) by clinic-pathologically studying a patient with paroxysmal atrioventricular (AV) block. Patient A long-surviving male patient with Sanfilippo syndrome type A presented with paroxysmal AV block at age 33 years. He then survived another 2.5 years after the onset of paroxysmal AV block and pacemaker implantation. Methods and results His cardiac histopathological examination at autopsy showed HS storage in the cardiac conduction system (CCS), especially in the atrioventricular node (AVN)-His bundle branches. Conclusion HS storage in the CCS might trigger AV block, arising from below the AVN-His bundle branches. This is the first description to indicate that HS might be an essential constituent of life-long CCS plasticity and that its storage in the CCS results in AV block.
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:0387-7604
1872-7131
DOI:10.1016/j.braindev.2016.12.008